Cite

HARVARD Citation

    Petiti, J. et al. (2020). Bcl‐xL represents a therapeutic target in Philadelphia negative myeloproliferative neoplasms. Journal of cellular and molecular medicine. 24 (18), pp. 10978-10986. [Online]. 
  
Back to record